11:06 AM EDT, 07/28/2025 (MT Newswires) -- Renovaro ( RENB ) announced on Monday that it has received multiple notices of allowance from the US Patent and Trademark Office in the field of unbiased drug discovery predictions.

The new patents address a novel federated learning architecture that enables artificial intelligence model training across decentralized healthcare datasets, such as those from hospitals and research institutions, without direct data exchange, according to the company.

Renovaro ( RENB ) shares were up 6% in recent trading.

Price: 0.33, Change: +0.02, Percent Change: +6.18